Notes
respectively of European Consulting and Contracting in Oncology (Trier, Germany) and MArS Market Access & Pricing Strategy GmbH (Weil am Rhein, Germany)
Reference
European Cancer Organisation. ECCO2017 NEWS: Delays in access to new cancer medicines and unjustifiable price rises for old ones disadvantage patients unnecessarily. Internet Document : 28 Jan 2017. Available from: URL: http://www.eccocongress.org/Global/News/ECCO2017-News/2017/01/ECCO2017-NEWS-Delays-in-access-to-new-cancer-medicines-and-unjustifiable-price-rises-for-old
Rights and permissions
About this article
Cite this article
Cancer patients in Europe not getting best access to drugs. PharmacoEcon Outcomes News 771, 1 (2017). https://doi.org/10.1007/s40274-017-3712-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-3712-6